Summary
- Current Price
- As of today, TEVA price is $39.19, down -2.56% on
- Current Price All-Time High
- TEVA price is currently -45.80% below its historical high of $72.31 set on
- Market Cap
- TEVA current market cap is $46B, up +117.04% over the past 365 days
- PE Ratio
- TEVA current PE ratio is 65.90
- Revenue
- TEVA current annual revenue is $17.46B, up +5.26% year-over-year
- Next Earnings
- The next earnings release for TEVA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Teva Pharmaceutical Industries Limited |
| Ticker | NYSE: TEVA |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | tevapharm.com |
| Employees | 37,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $39.19 | |
| Price, 1D Change | -2.56% | |
| Market Cap | $46B | |
| TTM Dividend Yield | - | |
| PE Ratio | 65.90 | |
| Beta | 0.73 | |
| Revenue | $17.46B | |
| Revenue, 1Y Change | +5.26% | |
| EPS | $1.22 | |
| EPS, 1Y Change | +183.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.32 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.22 | |
| EPS Estimate | $2.16 | N/A |
| EPS Est. Change | +76.86% | N/A |
| Revenue | $17.46B | |
| Revenue Estimate | $16.66B | N/A |
| Revenue Est. Change | -4.57% | N/A |
| Current Price | $39.19 | |
| Price Target | $42.00 | - |
| Price Tgt. Change | +7.17% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.47 | -$1.46 | -158.96% | |
| $2.63 | $1.22 | -53.51% | |
| $2.16 | N/A | +76.86% | |
| $3.04 | N/A | +149.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.42B | $16.59B | +1.01% | |
| $16.91B | $17.46B | +3.27% | |
| $16.66B | N/A | -4.57% | |
| $17.32B | N/A | -0.83% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +113.45% | |
| Price, 3Y | +282.34% | |
| Market Cap, 1Y | +117.04% | |
| Market Cap, 3Y | +297.91% | |
| Revenue, 1Y | +5.26% | |
| Revenue, 3Y | +17.53% | |
| EPS, 1Y | +183.93% | |
| EPS, 3Y | +155.67% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $39.19 | |
| SMA 200 | $33.44 | |
| SMA 50 | $36.10 | |
| EMA 200 | $32.44 | |
| EMA 50 | $36.74 | |
| MACD | $0.96 | |
| Beta | 0.73 | |
| ATR | $1.25 | |
| 14-Day RSI | 57.46 | |
| 10-Day Volatility | 38.05% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.32 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $17.46B | |
| EPS | $1.22 | |
| Gross Profit | $8.97B | |
| Gross Margin | 51.56% | |
| Operating Income | $3.98B | |
| Operating Margin | 22.90% | |
| Net Income | $1.43B | |
| Net Margin | 8.22% | |
| EBITDA | $4.99B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.16 | |
| 1.04 | ||
| 0.80 | ||
| - | ||
| 7 | ||
| 1.13 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 65.90 | |
| 2.62 | ||
| 5.90 | ||
| 13.79 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $7.91B | |
| $3.56B | ||
| $40.75B | ||
| $13.95B | ||
| $32.83B | ||
| $13.46B | ||
| Total Debt | $17.23B | |
| $1.82B | ||
| $2.53B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $15.97B | ||
| $4.99B | ||
| $8.43B | ||
| $0.00 | ||
| $1.01B | ||
| $0.00 | ||
| -$181.43M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $2.89B | ||
| -$519.09M | ||
| -$2.13B | ||
| Capex | $504.97M | |
| $2.38B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | ||
| UBS | → | |
| Barclays | → | |
| Piper Sandler | → | |
| Barclays | → | |
| UBS | → | |
| Truist Securities | → | |
| Piper Sandler | → | |
| JP Morgan | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with TEVA
FAQ
- What is the ticker symbol for Teva Pharmaceutical Industries Limited?
- The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA
- Does Teva Pharmaceutical Industries Limited pay dividends?
- No, Teva Pharmaceutical Industries Limited does not pay dividends
- What sector is Teva Pharmaceutical Industries Limited in?
- Teva Pharmaceutical Industries Limited is in the Healthcare sector
- What industry is Teva Pharmaceutical Industries Limited in?
- Teva Pharmaceutical Industries Limited is in the Specialty & Generic Drug Manufacturers industry
- What country is Teva Pharmaceutical Industries Limited based in?
- Teva Pharmaceutical Industries Limited is headquartered in Israel
- When did Teva Pharmaceutical Industries Limited go public?
- Teva Pharmaceutical Industries Limited initial public offering (IPO) was on February 16, 1982
- Is Teva Pharmaceutical Industries Limited in the S&P 500?
- No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index
- Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
- No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index
- Is Teva Pharmaceutical Industries Limited in the Dow Jones?
- No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index
- When was Teva Pharmaceutical Industries Limited last earnings report?
- Teva Pharmaceutical Industries Limited's most recent earnings report was on July 29, 2026
- When does Teva Pharmaceutical Industries Limited report earnings?
- The next expected earnings date for Teva Pharmaceutical Industries Limited is November 3, 2026
Data Sources & References
- TEVA Official Website www.tevapharm.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312526034532/0001193125-26-034532-index.htm
- TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
- TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva
